Sally Jennings

Sally Jennings joined the Gates MRI as the Head of Compliance & Risk Management, shortly after it opened its doors in Cambridge, in March 2018.

Sally began her legal career in the UK in private practice as a barrister-at-law appearing before the courts of England and Wales focusing on commercial litigation matters.

Following a job offer from a client, Sally left private practice to move in- house, thus began a + 25-year career in the Pharmaceutical industry. During that time, she held roles with increasing responsibility, seniority, and global scope. Moving from a senior legal director role at AstraZeneca, Sally became the Head of Legal and Company Secretary for Novartis’ UK and Ireland legal entitles responsible overseeing a team of lawyers providing legal support to its pharmaceutical, generics, OTC, veterinary, and optics divisions. Sally was later promoted to V.P. Corporate Counsel within Novartis’ newly acquired vaccines division, with global responsibility for its commercial and corporate legal matters and which entailed her moving to the United States in 2007 and leading a legal team spanning the EU, US and Asia Pac. Subsequently, Sally was further promoted to V.P. Global Head Legal, Product Development Quality and Strategy. After 14 years with Novartis and following the acquisition of its vaccines business by GSK, Sally became V.P. Legal Vaccines R&D and Risk Management, where she established and lead a global legal team supporting GSK’s Vaccines Research & Development strategy.

Sally is a Barrister-at Law admitted to the Bar of England and Wales and registered as in-house counsel with the MA Board of Bar Overseers. Sally Holds a B.A. (Hons), post Graduate Diploma in Law and a Master of Laws degree in International Commercial Law and Finance.